Analyst Ratings for Corcept Therapeutics (CORT)
CORT Rating Summary
CORT Price Target Summary
- Highest: $121.00 (Piper Sandler)
- Lowest: $30.00 (Wolfe Research)
- Average: $76.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$76.00 (+124.4%)
* Over Last 12-Mos
Rating Score: 3.7 / 10
Percentile Rank: 35%
Avg. $ Target:
$76.00 (+124.4%)
* Over Last 12-Mos
Rating Score: 3.7 / 10
Percentile Rank: 35%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/31/2025 | Wolfe Research | Kalpit Patel | Downgrade | Underperform (Peerperform) |
30.00 (N/A) |
70.19 (33.87) |
-51.75% | Details |
| 12/16/2025 | UBS | Ashwani Verma | New Coverage | Neutral (N/A) |
95.00 (N/A) |
87.99 (33.87) |
-61.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
